A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
NCT05199584
Adenoma, Adenoma, Islet Cell
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT02400996
A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.
Looking for future studies?
Notify MeAll sexes
Observational
The investigators did an analysis from a prospectively maintained database of patients who underwent pancreatic resections or nonresective procedures for neoplasms of the pancreas at Sir Ganga Ram Hospital from 1995 to 2013 and using pathological reports and preoperative CT scan as the gold standard, the investigators identified 40 patients with PENs.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Each participant was followed up for a period of 5 years
Of the 40 patients operated for Pancreatic Endocrine Neoplasms, using clinical criteria, histopathological analysis and preoperative imaging as gold standard, nonfunctioning and functioning tumours were identified. Similarly the number of benign and malignant lesions identified were recorded as per the WHO Classification of pancreatic endocrine tumours.
Medical College and Hospital Kolkata
Other
A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05199584
Adenoma, Adenoma, Islet Cell
Los Angeles, California, United States
View Trial DetailsNCT03879694
Adenoma, Adenoma, Islet Cell
Buffalo, New York, United States
View Trial DetailsNCT04505553
Adenocarcinoma, Adenoma
Seattle, Washington, United States
View Trial DetailsNCT02159989
Adenoma, Adenoma, Islet Cell
Houston, Texas, United States
View Trial Details